Search

everythinglearnresearchcommunity

for

Search:↓

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

A 5-year-old girl's scalp scarring and hair loss from lupus improved with specific medications.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Sudden hair whitening may be linked to immune system activity.

The study found that sweat glands normally suppress immune responses, but this is disrupted in certain skin diseases, possibly contributing to their development.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Inhibiting TYK2 can restore hair growth in alopecia areata.

A 16-year-old boy's facial condition improved with doxycycline, suggesting an immune response to hair follicle damage.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

Hypoalbuminemia can cause pleural effusion and needs careful treatment.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Anifrolumab effectively improved symptoms and reduced steroid use in Japanese patients with systemic lupus erythematosus.

Lymphatic vessels are essential for hair follicle regeneration and growth.

Restoring hair follicle immune privilege may help treat alopecia areata.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

The patient had paraneoplastic pemphigus without mucosal involvement.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Testing for various autoantibodies in Indian children with lupus can help predict disease symptoms and risks.

Adipose-derived stem cells can help repair tissue in lipodystrophy patients.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Scalp condition healed with prednisone and tacrolimus.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.